Atlas Trials

A Phase I/II Study of BI-505 in Conjunction With Autologous Stem Cell Transplant in Multiple Myeloma

Clinical trial NCT02756728 · TERMINATED

Trial details

NCT number
NCT02756728
Sponsor
BioInvent International AB
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2016-05-01
Primary completion
2016-12-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.